An AI/Genomics powered personalized app for men's sexual & reproductive ailments
advertisement
| Name | MenGO |
|---|---|
| Version | 2.9 |
| Update | Dec 16, 2023 |
| Size | 5 MB |
| Category | Health & Fitness |
| Installs | 1K+ |
| Developer | SystemOnSilicon Corporation |
| Android OS | Android 10+ |
| Google Play ID | com.systemonsilicon.mengo |
MenGO · Screenshots
MenGO · Description
As many as 30-40 % men across the world including India experience problem of Premature Ejaculation (PE) at some time of life. Erectile dysfunction (ED) affects approximately 100 million men worldwide and is currently recognized as a major public health problem. Nearly 25% of ED patients are below 30 years. A decade ago, this number was 5-7% (TOI). 27.5 million couples in India suffering from infertility. Only 45% of couples visit a doctor when they are trying to conceive; only 1 per cent of infertile couples seek treatment shown in research conducted by Inito
According to National Health and Social Life Survey (NHSLS) approximately 30%-70% of American males experience premature ejaculation. In the U.S., 83% of men experience nocturnal emissions at some time in their life. In Indonesia surveys have shown that 97% of men experience nocturnal emissions by the age of 24. 23.4% of men between the ages of 25 and 29 self ejaculate two to three times a week. 95% men admit that they self ejaculated at least once at some time in life. As many as 1000 people in the United States die each year performing Autoerotic asphyxiation.
Unlike Gynaecology, Andrology - men's health problems like Erectile dysfunction, Premature Ejaculation, Infertility and Semen abnormality etc has been less explored across the globe. Hence, in India as also elsewhere men are forced to go to unauthorized quacks for personal sexual problems. This is a major gap and there is a global need for a secure, reliable, scientific, analytics, user-friendly and efficient health-tech solution to address Men’s sexual and reproductive problems.
MenGO, a disruptive and pioneering digital health analytics app from SystemOnSilicon Corporation for Men's sexual and reproductive health problems, is built with advanced technologies including Artificial Intelligence, Cloud Computing, Machine Learning, Blockchain and Big Data Analytics. Using the power of Genomics and Molecular Biology, MenGO offers personalized services, smart recommendations and contextual guidance for andrological issues. In addition, MenGO also efficiently connects users to experts through its user friendly UI and securely manages health records.
An innovative and peerless medtech solution, MenGO brings news hopes to patients suffering from critical sexual and reproductive ailments and ushers in a new era of andrology analytics.
According to National Health and Social Life Survey (NHSLS) approximately 30%-70% of American males experience premature ejaculation. In the U.S., 83% of men experience nocturnal emissions at some time in their life. In Indonesia surveys have shown that 97% of men experience nocturnal emissions by the age of 24. 23.4% of men between the ages of 25 and 29 self ejaculate two to three times a week. 95% men admit that they self ejaculated at least once at some time in life. As many as 1000 people in the United States die each year performing Autoerotic asphyxiation.
Unlike Gynaecology, Andrology - men's health problems like Erectile dysfunction, Premature Ejaculation, Infertility and Semen abnormality etc has been less explored across the globe. Hence, in India as also elsewhere men are forced to go to unauthorized quacks for personal sexual problems. This is a major gap and there is a global need for a secure, reliable, scientific, analytics, user-friendly and efficient health-tech solution to address Men’s sexual and reproductive problems.
MenGO, a disruptive and pioneering digital health analytics app from SystemOnSilicon Corporation for Men's sexual and reproductive health problems, is built with advanced technologies including Artificial Intelligence, Cloud Computing, Machine Learning, Blockchain and Big Data Analytics. Using the power of Genomics and Molecular Biology, MenGO offers personalized services, smart recommendations and contextual guidance for andrological issues. In addition, MenGO also efficiently connects users to experts through its user friendly UI and securely manages health records.
An innovative and peerless medtech solution, MenGO brings news hopes to patients suffering from critical sexual and reproductive ailments and ushers in a new era of andrology analytics.
